Extracranial Arteriovenous Malformation

Overview

An extracranial arteriovenous malformation (AVM) is a rare, congenital vascular anomaly in which arteries connect directly to veins without the normal intervening capillary network. This creates a high‑flow “shunt” that can enlarge over time, leading to pain, bleeding, cosmetic deformity, and functional impairment. While AVMs can occur anywhere in the body, “extracranial” specifically refers to those located outside the brain and spinal cord—most commonly in the head and neck, trunk, or extremities.

Who is affected? Most AVMs are present at birth, but they often remain unnoticed until childhood, adolescence, or early adulthood when hormonal changes or trauma trigger rapid growth. Epidemiological data suggest an incidence of roughly 1–2 per 100,000 people worldwide, with a slight male predominance in some series (≈55% male) ^[1]. Because the condition is rare, exact prevalence figures vary by region and by the classification system used (e.g., ISSVA).

AVMs are not contagious and are not caused by lifestyle choices; they arise from errors in vascular development during embryogenesis.

Symptoms

Symptoms depend on the AVM’s size, location, and flow rate. The following list covers the full spectrum of possible manifestations:

• Pulsatile mass – A noticeable lump that feels like a heartbeat.
• Bruising or a “whooshing” sound (bruit) – Audible turbulence over the lesion.
• Skin discoloration – Ranges from pink to deep violet; may become warmer than surrounding skin.
• Pain or throbbing sensation – Often worsens with activity or hormonal changes.
• Bleeding or ulceration – Superficial lesions can rupture spontaneously.
• Swelling (edema) – Due to high‑pressure venous outflow.
• Functional impairment – Restricted movement when AVM involves a limb or facial muscles.
• Neurologic symptoms – If the AVM compresses nearby nerves (e.g., facial nerve palsy, weakness).
• Hearing loss or tinnitus – When the lesion is near the ear.
• Facial asymmetry or deformity – Common in head‑and‑neck AVMs.
• Growth acceleration – Lesions often enlarge rapidly during puberty, pregnancy, or after trauma.
• Cardiac overload – Very large high‑flow AVMs can cause high‑output cardiac failure, especially in infants.

Causes and Risk Factors

Underlying cause

Extracranial AVMs are primarily developmental anomalies. During embryonic vascular formation, signaling pathways (e.g., VEGF, TGF‑β, Notch) guide the differentiation of arteries, veins, and capillaries. Mutations or somatic mosaic changes in genes such as RASA1, ENG, AKT1, and PIK3CA have been identified in some patients, linking AVMs to broader vascular malformation syndromes (e.g., Capillary Malformation‑Arteriovenous Malformation syndrome) ^[2].

Risk factors

• Family history of hereditary vascular malformation syndromes.
• Hormonal influences – Puberty, pregnancy, and oral contraceptives can accelerate AVM growth.
• Physical trauma – Minor injuries may precipitate rapid expansion.
• Previous incomplete treatment – Inadequate embolization or surgery can lead to recurrence.

There are no modifiable lifestyle risk factors (e.g., smoking, diet) directly linked to the development of an AVM.

Diagnosis

Accurate diagnosis requires a combination of clinical assessment and imaging. The goals are to confirm the high‑flow nature, map the lesion’s extent, and plan treatment.

Clinical examination

• Palpation for pulsatility.
• Auscultation for bruit.
• Photographs for documentation of skin changes.

Imaging studies

• Doppler ultrasound – First‑line, non‑invasive; shows arterialized venous flow and helps differentiate AVM from low‑flow malformations.
• Magnetic Resonance Angiography (MRA) – Provides detailed 3‑D anatomy without radiation; useful for head and neck lesions.
• Computed Tomography Angiography (CTA) – Faster than MRA, excellent for bone involvement or when MRI is contraindicated.
• Digital Subtraction Angiography (DSA) – Gold standard; visualizes feeding arteries, nidus, and draining veins; also allows for endovascular therapy in the same session.
• Contrast‑enhanced ultrasound (CEUS) – Emerging tool for real‑time flow analysis.

Laboratory tests

Routine labs are generally normal, but a complete blood count and coagulation profile are obtained before any invasive procedure. In cases of high‑output cardiac failure, BNP or echocardiography may be indicated.

Treatment Options

Treatment is individualized based on lesion size, location, symptoms, and patient preferences. The primary aim is to control symptoms, prevent progression, and minimize aesthetic or functional loss.

Conservative Management

• Observation – Small, asymptomatic AVMs may be monitored with periodic imaging (usually every 12–24 months).
• Analgesia – NSAIDs or acetaminophen for mild pain; avoid aspirin if bleeding risk is high.

Endovascular Therapy

Embolization is the cornerstone for most extracranial AVMs.

• Particle embolization (polyvinyl alcohol, trisacryl gelatin particles).
• Liquid agents – Onyx® (ethylene‑vinyl alcohol copolymer), N‑butyl cyanoacrylate (NBCA).
• Coils or detachable balloons – Used to occlude larger feeding arteries.
• Typically performed by an interventional radiologist under fluoroscopic guidance; multiple sessions often required.

Surgical Resection

• Indicated when the AVM is well‑circumscribed, causing significant deformity, or when embolization alone is insufficient.
• Pre‑operative embolization reduces intra‑operative blood loss.
• Risk of recurrence if any nidus tissue remains.

Adjunctive Therapies

• Laser therapy (e.g., pulsed dye laser) – Useful for superficial skin discoloration.
• Radiofrequency ablation or cryotherapy – Rarely employed for small, localized lesions.

Pharmacologic Options

Currently, no FDA‑approved systemic drugs target AVMs, but emerging data suggest potential roles for:

• Sirolimus (rapamycin) – An mTOR inhibitor; case series show reduction in lesion size and pain for complex AVMs ^[3].
• Bevacizumab – Anti‑VEGF antibody; used off‑label in refractory cases.

These agents are generally reserved for patients who are not surgical candidates and should be managed by a specialist experienced in vascular anomalies.

Lifestyle & Supportive Measures

• Avoid activities that cause direct trauma to the lesion.
• Use compression garments only if recommended by a specialist (may help with swelling).
• Regular follow‑up with a multidisciplinary team (vascular surgeon, interventional radiologist, dermatologist, and physical therapist).

Living with Extracranial Arteriovenous Malformation

Daily Management Tips

• Skin care – Keep the overlying skin clean and moisturized; watch for ulceration.
• Heat exposure – Warm environments can increase blood flow and exacerbate symptoms; use air‑conditioning or cool packs as needed.
• Stress reduction – Stress hormones may augment blood flow; yoga, meditation, and adequate sleep are beneficial.
• Physical activity – Low‑impact exercises (e.g., swimming, stationary cycling) maintain cardiovascular health without over‑loading the lesion.
• Dental & ENT care – For head‑and‑neck AVMs, inform dentists and ENT specialists; prophylactic antibiotics may be needed before invasive procedures.
• Pregnancy planning – Discuss risks with an obstetrician; many AVMs enlarge during pregnancy and may need pre‑pregnancy embolization.
• Psychosocial support – Cosmetic concerns are common; counseling or support groups (e.g., Vascular Birthmarks Foundation) can improve quality of life.

Follow‑up Schedule

Typical follow‑up intervals:

• Stable, asymptomatic lesions: imaging every 12–24 months.
• Post‑embolization or post‑surgery: MRI/MRA at 3 months, then annually for at least 5 years.
• Any new pain, swelling, or skin changes: prompt clinical review.

Prevention

Because extracranial AVMs are congenital, primary prevention is not possible. However, secondary prevention—preventing growth or complications—includes:

• Early diagnosis and treatment of small lesions before they become high‑flow.
• Avoiding unnecessary trauma (e.g., sports that involve repeated blows to the affected area).
• Managing hormonal influences when possible (e.g., discussing contraceptive options with a physician).
• Adhering to follow‑up plans to catch recurrences early.

Complications

If left untreated or inadequately managed, extracranial AVMs can lead to serious problems:

• Severe hemorrhage – Particularly with superficial lesions or after trauma.
• Chronic pain and ulceration – Leading to infection and possible sepsis.
• High‑output cardiac failure – Large AVMs can shunt enough blood to overload the heart, especially in infants and young children.
• Functional impairment – Limitation of limb movement, speech or swallowing difficulties when lesions involve facial or neck structures.
• Disfigurement – Cosmetic deformities may cause psychosocial distress.
• Recurrence – Incomplete removal or embolization can allow the nidus to regrow.

When to Seek Emergency Care

---

**References**

1. Meyer et al., “Arteriovenous Malformations: Epidemiology and Clinical Presentation,” *Vascular Medicine*, 2016.
2. Ramesh et al., “Genetic Insights into Arteriovenous Malformations,” *Journal of Clinical Investigation*, 2020.
3. Garg et al., “Sirolimus Therapy for Complex Vascular Malformations,” *British Journal of Dermatology*, 2019.
4. Mayo Clinic – Arteriovenous Malformation
5. CDC – Vascular Malformations
6. NIH – Vascular Malformations